Develops gene‑editing technologies, engineered cell lines, and research reagents used by pharmaceutical and biotechnology companies in drug discovery and genomic research. Its platforms, built around CRISPR and other gene‑modulation tools, support target validation, biomarker discovery, and preclini...
1 member of Congress has disclosed 1 trade in Horizon Discovery Ordinary (HZDDY), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-05-11 | Donald Sternoff Beyer | sell | $1K – $15K |